Doxycycline Patent Expiration

Doxycycline is Used for treating inflammatory lesions of rosacea. It was first introduced by Pfizer Laboratories Div Pfizer Inc in its drug Vibramycin on Approved Prior to Jan 1, 1982. Other drugs containing Doxycycline are Oracea, Monodox. 26 different companies have introduced drugs containing Doxycycline.


Doxycycline Patents

Given below is the list of patents protecting Doxycycline, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Oracea US7749532 Once daily formulations of tetracyclines Dec 19, 2027 Galderma Labs Lp
Oracea US8206740 Once daily formulations of tetracyclines Dec 24, 2025 Galderma Labs Lp
Oracea US8394405 Once daily formulations of tetracyclines Apr 07, 2024

(Expired)

Galderma Labs Lp
Oracea US8394406 Once daily formulations of tetracyclines Apr 07, 2024

(Expired)

Galderma Labs Lp
Oracea US8470364 Once daily formulations of tetracyclines Apr 07, 2024

(Expired)

Galderma Labs Lp
Oracea US8709478 Once daily formulations of tetracyclines Apr 07, 2024

(Expired)

Galderma Labs Lp
Oracea US10058564 Methods of treating acne Apr 05, 2022

(Expired)

Galderma Labs Lp
Oracea US7211267 Methods of treating acne Apr 05, 2022

(Expired)

Galderma Labs Lp
Oracea US7232572 Methods of treating rosacea Apr 05, 2022

(Expired)

Galderma Labs Lp
Oracea US8603506 Methods of treating acne Apr 05, 2022

(Expired)

Galderma Labs Lp
Oracea US9241946 Methods of treating acne Apr 05, 2022

(Expired)

Galderma Labs Lp
Oracea US5789395 Method of using tetracycline compounds for inhibition of endogenous nitric oxide production Aug 30, 2016

(Expired)

Galderma Labs Lp
Oracea US5919775 Method for inhibiting expression of inducible nitric oxide synthase with tetracycline Aug 30, 2016

(Expired)

Galderma Labs Lp



Doxycycline's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Doxycycline Generic API Manufacturers

Several generic applications have been filed for Doxycycline. The first generic version for Doxycycline was by Rachelle Laboratories Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Macleods Pharmaceuticals Ltd and was approved on Mar 27, 2025.

Given below is the list of companies who have filed for Doxycycline generic, along with the locations of their manufacturing plants worldwide.